Corporate Events

Qol Holdings Co., Ltd. (TSE:3034) agreed to acquire an unknown majority stake in MY Co., Ltd. from an individual on September 30, 2026. Upon completion, MY Co., Ltd. will become a consolidated subsidiary of Qol Holdings Co., Ltd. The expected completion of the transaction is October 22, 2026.

Qol Holdings Co., Ltd. (TSE:3034) agreed to acquire an unknown majority stake in MEDIKA MENTE Co., Ltd. from two individuals on September 30, 2026. Upon completion, MEDIKA MENTE Co., Ltd. will become a consolidated subsidiary of Qol Holdings Co., Ltd. The expected completion of the transaction is October 22, 2026.

Qol Holdings Co., Ltd. (TSE:3034) acquired MH2 Co., Ltd. on August 5, 2026. Qol Holdings Co., Ltd. (TSE:3034) completed the acquisition of MH2 Co., Ltd. on August 5, 2026.

Qol Holdings Co., Ltd., ¥ 27.0, Cash Dividend, Sep-29-2026

Qol Holdings Co., Ltd. announced that they will report Q1, 2027 results on Aug 07, 2026

Qol Holdings Co., Ltd. revised dividend guidance for the year-end of the fiscal year ended March 31, 2026. For the, year-end, the company now expects to pay a dividend of JPY 27.00 against previous guidance of JPY 23.00 per share. Record date March 31, 2026. Total amount of dividends JPY 1,014 million. Effective date: June 12, 2026. Source of dividends: Retained earnings. Reason: With respect to dividends, in consideration of securing internal reserves necessary for future business development and management foundation enhancement, the Group's basic policy is to continue providing shareholders with the stable return of profits. Regarding the dividend per share for the fiscal year ended March 31,2026, the Company announced on May 9, 2025, that the total annual dividend would be JPY 46 per share. The breakdown of the annual dividend of JPY 46 is JPY 23 per share at the end of the second quarter and JPY 23 per share at the fiscal year-end. As a result of the steady progress of the business performance and financial condition for the fiscal year ended March 31, 2026, the Company increases its year-end cash dividend by JPY 4 per share to JPY 27 per share. Together with the interim dividend, the Company will therefore pay annual cash dividends of JPY 50 per share, an increase of JPY 16 per share from the prior fiscal year.

Qol Holdings Co., Ltd. expected to report Q1 2027 results on August 12, 2026. This event was calculated by S&P Global (Created on August 5, 2026).

Qol Holdings Co., Ltd., Annual General Meeting, Jun 26, 2026.

Qol Holdings Co., Ltd., Board Meeting, May 12, 2026. Agenda: To consider to pay dividends of surplus.

Qol Holdings Co., Ltd. announced that they will report fiscal year 2026 results on May 14, 2026

Qol Holdings Co., Ltd. announced that Mr. Yuji Suzuki, who currently serves as a Director (excluding Audit & Supervisory Committee members), is scheduled to retire at the Company’s 34th Annual General Meeting of Shareholders to be held in June 2026. Following his retirement, he is expected to assume the roles of Deputy Chief of the Company’s Phar Business Headquarters and Executive Director of Qol Co., Ltd., effective April 1, 2026.

Qol Holdings Co., Ltd. announced that With respect to personnel changes effective April 1, 2026, Takayoshi Ishii will continue as Representative and Senior Executive Director while additionally serving as Chief of the Corporate Strategy Headquarters, and Kiyonobu Fukumitsu will continue as Representative and Executive Director while also assuming the role of Chief of the Business Management Headquarters. Shinobu Karasawa will continue as Executive Director and assume the position of Chief of the Pharmacy Business Headquarters. Yutaka Togashi will continue as Director and become Chief of the Human Resources and Education Headquarters while also serving as General Manager of the Human Resources Planning Dept., having previously served as General Manager of the Human Resources Planning Dept. Kei Imai will continue as Director and be appointed Chief of the Corporate Planning Headquarters, having previously served as General Manager of the Corporate Planning Dept. Yuji Suzuki will continue as Director and be appointed Deputy Chief of the Pharmacy Business Headquarters, having previously served as General Manager of the Pharmacy Business Development Function Dept. Kojiro Shimokawara will continue as General Manager of the Business Development Dept. while being assigned to the Corporate Strategy Headquarters. Jun Kawaguchi will assume the role of Chief of the General Affairs and Disaster Countermeasures Headquarters while serving as General Manager of both the General and Legal Affairs Dept. and the Disaster Countermeasures Dept., having previously served as General Manager of the General and Legal Affairs Dept. and General Manager of the Disaster Countermeasures Dept. Meeting date: March 25, 2026.

Qol Holdings Co., Ltd. announced that, at the meeting of the Board of Directors held today, it resolved to implement organizational and personnel changes as set forth below. With respect to organizational changes effective April 1, 2026, in order to establish an integrated management structure across its Pharmacy Business, BPO Contracting Businesses, and Pharmaceutical Manufacturing Business, the Company will abolish its current function-based organization and transition to a headquarters-based organization. As part of establishing the new headquarters structure, the Company will newly establish the Corporate Planning Headquarters, the Corporate Strategy Headquarters, the Business Management Headquarters, the General Affairs and Disaster Countermeasures Headquarters, the Human Resources and Education Headquarters, and the Pharmacy Business Headquarters. Under this structure, the Corporate Planning Dept. will be placed under the Corporate Planning Headquarters; the Business Development Dept. and the Distribution Policy and Procurement Dept. will be placed under the Corporate Strategy Headquarters; the Finance Dept. and the Information Systems Dept. will be placed under the Business Management Headquarters; the General and Legal Affairs Dept. and the Disaster Countermeasures Dept. will be placed under the General Affairs and Disaster Countermeasures Headquarters; and the Human Resources Planning Dept. will be placed under the Human Resources and Education Headquarters. In addition, to strengthen the promotion of the BPO Contracting Businesses and Pharmaceutical Manufacturing Business, the Medical-Related Business Promotion Dept. will be established under the Corporate Planning Headquarters. Furthermore, in order to further strengthen human resources development across the entire Company, the Education Promoting Dept. will be renamed the Human Resources Education Dept. and placed under the Human Resources and Education Headquarters.

Qol Holdings Co., Ltd., Board Meeting, Mar 25, 2026. Agenda: To consider Executive Changes; and to consider the other matters if any.

Qol Holdings Co., Ltd. expected to report Fiscal Year 2026 results on May 8, 2026. This event was calculated by S&P Global (Created on February 16, 2026).

Qol Holdings Co., Ltd. announced dividend for the second quarter end of the fiscal year ending March 31, 2026. For the period, the company announced dividend of JPY 23.00 per share against JPY 17.00 per share a year ago. Scheduled date to commence dividend payments: December 1, 2025.

Qol Holdings Co., Ltd. provided consolidated earnings guidance for the Fiscal Year Ending March 31, 2026. For the full year, the company expects net sales of ¥280,000 million, operating profit of ¥15,500 million, profit attributable to owners of parent of ¥7,000 million and basic earnings per share of ¥186.51 per share.

Qol Holdings Co., Ltd., ¥ 23.0, Cash Dividend, Mar-30-2026

Qol Holdings Co., Ltd. expected to report Q3 2026 results on February 6, 2026. This event was calculated by S&P Global (Created on November 7, 2025).